SAFETY OF LEMBOREXANT IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)

被引：1
|
作者：
Rosenberg, Russell [1 ]
Filippov, Gleb [2 ]
LoPresti, Antonia [2 ]
Kumar, Dinesh [2 ]
Murphy, Patricia [2 ]
Moline, Margaret [2 ]
机构：
[1] NeuroTrials Res Inc, Atlanta, GA USA
[2] Eisai Inc, Tokyo, Japan
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2019年 / 27卷 / 03期
关键词：
D O I：
10.1016/j.jagp.2019.01.109
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR - 21
引用
收藏
页码：S155 / S156
页数：2
相关论文
共 50 条
  • [41] LONG-TERM PERCEPTION OF MEDICATION EFFECTIVENESS IN ELDERLY SUBJECTS WITH INSOMNIA RECEIVING LEMBOREXANT FOR UP TO 12 MONTHS
    Drake, Christopher
    Yardley, Jane
    Pinner, Kate
    Perdomo, Carlos
    Moline, Margaret
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (04): : S74 - S74
  • [42] SUBJECTIVE RATINGS OF MEDICATION STRENGTH OVER 6 MONTHS IN ELDERLY SUBJECTS WITH MODERATE OR SEVERE INSOMNIA TREATED WITH LEMBOREXANT
    Drake, Christopher
    Yardley, Jane
    Pinner, Kate
    Moline, Margaret
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (04): : S74 - S75
  • [43] Consistency of objective sleep maintenance data between Chinese and North American/European subjects with insomnia in lemborexant Phase 3 studies
    Moline, Margaret
    Cheng, Jocelyn
    Kumar, Dinesh
    Takase, Takao
    Yamakawa, Naoto
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [44] EFFECT OF LEMBOREXANT ON SLEEP ARCHITECTURE IN SUBJECTS WITH COMORBID INSOMNIA AND MILD OBSTRUCTIVE SLEEP APNEA FROM A PH 3 TRIAL
    Kushida, Clete
    Zammit, Gary
    Cheng, Jocelyn
    Kumar, Dinesh
    Moline, Margaret
    SLEEP, 2023, 46 : A157 - A157
  • [45] Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials
    Gotfried, Mark H.
    Auerbach, Sanford H.
    Dang-Vu, Thien Thanh
    Mishima, Kazuo
    Kumar, Dinesh
    Moline, Margaret
    Malhotra, Manoj
    DRUGS & AGING, 2024, 41 (09) : 741 - 752
  • [46] Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease
    Cheng, Jocelyn Y.
    Lorch, Daniel
    Hall, Nancy
    Moline, Margaret
    JOURNAL OF SLEEP RESEARCH, 2025, 34 (02)
  • [47] Efficacy and Safety Results from a Phase 3 Study of Biosimilar Candidate ABP 710 in Subjects with Moderate to Severe RA
    Genovese, Mark
    Sanchez-Burson, Juan
    Balazs, Eva
    Everding, Andrea
    Oh, MyungShin
    Fanjiang, Gary
    Cohen, Stanley
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder
    Roth, Thomas
    Rosenberg, Russell
    Morin, Charles M.
    Yardley, Jane
    Pinner, Kate
    Perdomo, Carlos
    Atkins, Norman, Jr.
    Pappadopulos, Elizabeth
    Malhotra, Manoj
    Moline, Margaret
    SLEEP MEDICINE, 2022, 90 : 249 - 257
  • [49] LANADELUMAB SAFETY AND IMMUNOGENICITY: RESULTS FROM THE PHASE 3 HELP STUDY
    Johnston, D.
    Banerji, A.
    Riedl, M.
    Zuraw, B.
    Lumry, W.
    Bernstein, J.
    Li, H.
    Lu, P.
    Hao, J.
    Gower, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S36 - S36
  • [50] Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies
    Uchiyama, Makoto
    Mishima, Kazuo
    Yagi, Tomoko
    Yoshihara, Tatsuya
    Eto, Takashi
    Muehlan, Clemens
    Togo, Osamu
    Inoue, Yuichi
    JOURNAL OF SLEEP RESEARCH, 2025, 34 (01)
12345